Raymond James raised the firm’s price target on Delek US (DK) to $28 from $23 and keeps an Outperform rating on the shares. Delek can participate in upside in the refining macro, especially as lower spending levels and business diversification provides a bridge to full company value optimization, the analyst tells investors in a research note.
Elevate Your Investing Strategy:
- Take advantage of TipRanks Premium at 50% off! Unlock powerful investing tools, advanced data, and expert analyst insights to help you invest with confidence.
- Make smarter investment decisions with TipRanks' Smart Investor Picks, delivered to your inbox every week.
Published first on TheFly – the ultimate source for real-time, market-moving breaking financial news. Try Now>>
Read More on DK:
- Delek US price target raised to $20 from $14 at Scotiabank
- Delek US price target raised to $27 from $23 at Mizuho
- Cautious Outlook for Delek US Holdings Amidst Projected Earnings Shortfall and Limited Growth
- Delek US price target raised to $23 from $22 at Raymond James
- Delek US price target raised to $15 from $11 at Wells Fargo